Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

WaveTec Vision Systems brings in $15.9mm through its Series D round

Executive Summary

WaveTec Vision Systems Inc. (cataract surgery devices) has raised $15.9mm through its Series D venture round to eight investors, including new backers Versant Ventures (lead) and Gund Investment Corp., and returning shareholders Accuitive Medical Ventures and De Novo Ventures. According to the company’s Form D filing, it could bring in another $2mm before closing the financing. Funds will be used to commercialize WaveTec’s Orange intraoperative wavefront aberrometer, which enables cataract surgeons to measure refraction during surgery. The company raised $3.5mm through the sale of debt and other securities this past January.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register